Letters to the Editor
Prenatal Therapy in Developmental Disorders: Drug Targeting via Intra-Amniotic Injection to Treat X-Linked Hypohidrotic Ectodermal Dysplasia

https://doi.org/10.1038/jid.2014.264Get rights and content
Under an Elsevier user license
open archive

Cited by (0)

Kenneth Huttner is an employee of Edimer Pharmaceuticals Inc.; Pascal Schneider holds shares in this company. Holm Schneider is a member of the clinical advisory board of Edimer Pharmaceuticals.